Initial Management of Suspected Deep Vein Thrombosis and Pulmonary Embolism

Immediate Clinical Assessment and Risk Stratification

For patients with suspected DVT or PE, the American Thoracic Society recommends initiating anticoagulation immediately while awaiting diagnostic confirmation if clinical suspicion is high, and proceeding with same-day imaging whenever reasonably practical 1
The American College of Chest Physicians suggests applying Wells' Criteria or Revised Geneva Score to stratify pretest probability before ordering diagnostic tests 2
For high clinical suspicion of PE, the American College of Chest Physicians recommends starting parenteral anticoagulation immediately while awaiting diagnostic test results 3
For intermediate clinical suspicion of PE, the American College of Chest Physicians suggests initiating parenteral anticoagulation if diagnostic results will be delayed more than 4 hours 3
For low clinical suspicion of PE, the American College of Chest Physicians recommends that anticoagulation can be withheld if test results are expected within 24 hours 3

The American Thoracic Society recommends immediately assessing for signs of massive PE: systolic blood pressure <90 mm Hg, heart rate >110 bpm, oxygen saturation <90% on room air, or requirement for inotropes 1, 4
The American College of Chest Physicians suggests checking for engorged neck veins and right ventricular gallop as additional indicators of hemodynamic compromise 4
Hemodynamically unstable patients require immediate thrombolysis consideration and should not be delayed for additional imaging, according to the American College of Chest Physicians 4

The National Comprehensive Cancer Network recommends obtaining complete blood count with platelet count, PT, aPTT, liver and kidney function tests as part of initial workup 2, 5
The National Comprehensive Cancer Network suggests measuring N-terminal pro-BNP and troponin for PE cases to assess right ventricular strain 2
The American College of Chest Physicians recommends that D-dimer testing should be used only in low-risk DVT patients or moderate-risk PE patients to rule out disease 4

The American College of Chest Physicians recommends initiating parenteral anticoagulation immediately with LMWH, fondaparinux, IV UFH, or SC UFH for confirmed PE 3
The American College of Chest Physicians suggests that LMWH or fondaparinux is preferred over IV UFH for most patients with acute PE 3
The American Thoracic Society recommends that apixaban or rivaroxaban can be initiated immediately without parenteral bridging for both DVT and PE 1
The American College of Chest Physicians recommends that edoxaban or dabigatran require initial LMWH bridging for at least 5 days before starting 1

The American Thoracic Society recommends using PESI (Pulmonary Embolism Severity Index) or sPESI to identify low-risk patients eligible for outpatient care 1
The American Thoracic Society suggests applying exclusion criteria before outpatient management: hemodynamic instability, oxygen saturation <90%, active bleeding risk, severe pain requiring opiates, severe kidney disease (eGFR <30 mL/min), inadequate home support 1
The American Thoracic Society recommends that RV dilatation on imaging with elevated cardiac biomarkers should prompt inpatient admission for observation 1

The American College of Chest Physicians recommends systemic thrombolysis for massive PE with hemodynamic instability 3, 4
The American College of Chest Physicians suggests that catheter-directed thrombolysis may be considered in centers with appropriate expertise, especially for patients at intermediate-to-high bleeding risk 6
The American Society of Hematology recommends that IVC filters are not recommended when anticoagulation is possible 6
The American Society of Hematology suggests considering retrievable IVC filter only when absolute contraindication to anticoagulation exists, with retrieval as soon as anticoagulation becomes feasible 6
The American Society of Clinical Oncology recommends that cancer patients should receive LMWH over warfarin for long-term DVT/PE treatment 5
The American Society of Clinical Oncology suggests that more frequent clinical assessment is needed due to higher recurrence and bleeding risk 5

The American College of Chest Physicians recommends not withholding anticoagulation in high-risk patients while awaiting imaging—treat empirically 1, 3
The American College of Chest Physicians suggests not using compression stockings routinely—evidence shows they do not reduce post-thrombotic syndrome 3
The American College of Chest Physicians recommends not missing bilateral edema from other causes by focusing solely on DVT 5
The American College of Chest Physicians suggests not using high-intensity warfarin (INR 3.1-4.0) or low-intensity warfarin (INR 1.5-1.9)—both are inferior to standard INR 2.0-3.0 3